Tocolytic therapy with preterm premature rupture of membranes.
Tocolytic therapy with preterm premature rupture of membranes continues to be a controversial issue. Articles focusing on potential benefits and adverse outcomes associated with tocolysis in this disease process are reviewed. Although there may be some short-term neonatal benefit, further investigation of this issue is warranted.
Fontenot
T
T
Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, University of Kentucky Medical Center, Lexington, Kentucky, USA. mtfont@uky.edu
Lewis
D F
DF
D019072:Antibiotic Prophylaxis; D005260:Female; D005322:Premature Rupture of Fetal Membranes / Q000517:prevention & control*; D006801:Humans; D007231:Infant, Newborn; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000517:prevention & control; D015145:Tocolysis / Q000379:methods*